The antiapoptotic effect of granulocyte colony-stimulating factor reduces infarct size and prevents heart failure development in rats

Even though our study also presents some limitations, including sample size, it showed a significant correlation between CFH gene polymorphism and the treatment outcome in

Patients undergoing locoregional treatment for downstaging also showed a significant reduction in the size of the largest nodule in mm before and after treatment (Figure 1.2)..

In our study, even though the distribution of the fail- ure frequencies showed a numerically lower failure rate in premature infants treated with nIPPV compared to those

Treatment was begun with a granulocyte colony stimulating factor (G-CSF), methotrexate was kept and the dosage of oral prednisone raised to 40 mg/day, taken for three months,

Objective: The aim of this study was to compare a fractionated dose of 15 ␮g G-CSF/kg of body weight and the conventional dose of granulocyte-colony stimulating factor in respect to

Our objectives were to analyze the accuracy of ECHO in determining infarction size in rats during the first days following coronary occlusion and to test whether a simplified

In contrast, it was observed the characteristic decrease in this ratio in hypertensive 2K1C animals when compared to Sham groups (p<0.01, two-way ANOVA) and that it was

Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter